TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography

• Status: Unknown status
• Trial end date: 2021-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is a double-blind placebo-controlled randomized clinical trial to test the use of tamoxifen or lidocaine for diminishing the pain and discomfort while performing mammography, intending to include 450 patients distributed between the three groups.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Universidade Federal de Goias
• Treatments: Lidocaine; Tamoxifen

Criteria

Inclusion Criteria:

• Patients with mastalgia in the mastology program with age 40 who have indication for mammography.

Exclusion Criteria:

• Patients who do not wish to participate in the study

• Patients who underwent prosthetic silicone implants

• Patients who mammoplasty (breast reduction or mastopexy) were submitted

• Pregnant women

• Patients allergic to tamoxifen or to lidocaine, heart disease, or patients with a history deep vein thrombosis.